1998 articles in this topic
Engineered immune cells originally designed for cancer now target lupus, arthritis, and age-related conditions with fewer side effects.
New research reveals mitochondrial health determines senolytic drug effectiveness, offering strategies to enhance anti-aging treatments.
New research reveals how aging cells in the brain create a vicious cycle that accelerates Alzheimer's progression and neurodegeneration.
New research reveals how to precisely target harmful aging signals that fuel cancer growth, opening doors for better treatments.
New research maps the connection between cellular senescence, chronic inflammation, and cardiovascular disease progression.
Researchers discover why platinum chemotherapy stops working and identify combination treatments that could improve outcomes.
Scientists identify cellular senescence as key driver of liver disease, opening doors to precision anti-aging treatments.
Researchers developed a method to artificially age stem cells, creating better models for studying neurodegeneration and other age-related conditions.
New small-molecule approach offers safer alternative to genetic reprogramming for turning back the cellular clock.
BIIB080 antisense therapy targeting tau protein demonstrated consistent trends toward slowing cognitive and functional decline in mild Alzheimer's patients.
New research reveals how HIV permanently alters gene expression patterns, driving accelerated aging and chronic diseases even with viral suppression.
Blood stem cell mutations may actually improve immune checkpoint therapy effectiveness against cancer tumors.
